Device investment climate
This article was originally published in The Gray Sheet
Executive Summary
Results of an industry survey polling 5000 device executives and investors will be released April 9, Minneapolis firm Oppenheimer Wolff & Donnelly announces March 25. Questionnaire respondents were to compare the medical device investment climate to that of biotech and pharmaceuticals, evaluate opportunities in various product subsets and geographic areas and gauge the effect of threats including war with Iraq and terrorism in the U.S...